Administration of parenteral iron and mortality among hemodialysis patients. - Wikidata - wikimedia - TriplyDB

Administration of parenteral iron and mortality among hemodialysis patients.

Administration of parenteral iron and mortality among hemodialysis patients.

http://www.wikidata.org/entity/Q47578282

about

Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century Safety concerns about intravenous iron therapy in patients with chronic kidney disease Safety of intravenous iron formulations: facts and folklore Considerations and challenges in defining optimal iron utilization in hemodialysis Efficiency of Original versus Generic Intravenous Iron Formulations in Patients on Haemodialysis Safety of intravenous iron in hemodialysis patients.Exploring the effect of erythropoietin on mortality using USRDS data.Atherogenesis and iron: from epidemiology to cellular level.Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy.Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.Intravenous iron exposure and mortality in patients on hemodialysis Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.Iron supplementation and mortality in incident dialysis patients: an observational study.Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis.Correction of iron deficiency in the cardiorenal syndrome Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.Iron therapy for renal anemia: how much needed, how much harmful?Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study.Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study.Intravenous iron therapy: well-tolerated, yet not harmless.Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex.History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients.Erythropoiesis-stimulating agent hyporesponsiveness.History-adjusted marginal structural models for estimating time-varying effect modification.Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality?Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation.Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study.Intravenous iron in heart failure: beyond targeting anemia.Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?Anaemia management and mortality risk in chronic kidney disease.The Labile Side of Iron Supplementation in CKD Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity.

P2860

Q26752664-EC1475DE-E8F0-453F-843A-9AFC0FB81258 Q26764881-D9266C9F-6604-42C9-AC6E-B643D190B3B9 Q26853397-26DAB627-B5EF-445D-A520-269660EBD197 Q28088564-6E3BB701-5A6B-4F85-9FFD-325172CD7C62 Q28547636-F8A69252-7978-4BD0-9A36-A0E608730E48 Q30234981-F0FF266F-0382-466B-B711-8B182C4293B5 Q30620811-BE232207-0497-47C3-BA6C-27D3D2B2EFEE Q33595279-3F535EC8-95FE-444A-AD63-F2C869227C4C Q33829876-3F954A5A-2436-4623-9CC2-CF1B94CC0961 Q33832885-14B226B0-8881-46BC-9461-667C24C3ED0C Q33985838-3596A2D5-CF8A-46F0-9E37-BE725C796A84 Q34255473-4A4543D9-3E09-4240-B537-67C2781B4ECA Q34333986-3C86D77A-D4DB-42BC-8106-353FC18E8254 Q34427619-DE2788F6-375C-47DB-9E98-0333FA9B7722 Q34455198-F7E09098-BD7E-4212-9987-AC3DE0C5A81D Q34506972-074BECD4-7007-411A-996E-FAFA2E33A03F Q34612274-BBC00EEC-4C6B-4FD0-95C9-1F352DFD7C55 Q34654443-C734CA71-375F-4EF3-980B-3BAFC4C1F80F Q34704499-CD9267B1-408F-4DD0-937A-D90DF5721EA4 Q34989324-1CBADD1D-2F41-4105-B807-10974FDFFCCF Q35041088-4AD56789-7FAC-4B22-920C-1BAD90301F5A Q35474305-7E29E926-D498-4658-BBC1-D3E91BC0C5D7 Q35650627-15B6B852-5EF6-445D-B4EB-FECDD312EE75 Q35936604-E8BC7730-1317-490D-97B8-DFA7B9DC79CC Q36118510-5F599C8B-AE69-44D1-B270-A7FE60BDA31D Q36310902-8CDBB72F-EB67-42E7-9B02-7F40D6D86228 Q36577123-3A48C46E-734D-4325-9AAB-AD1A2DAC8B00 Q36662013-99D2764D-C1BE-4E28-BB3B-939BD411E60B Q36884461-1E0CF167-FE84-40ED-945E-F6DE463E5B06 Q36924003-DC898EAA-D27A-4513-AF4B-2084ED44EE51 Q36925390-3B3073BA-6889-4F0D-A211-0CB19FE343FE Q36944677-D8593C31-CEA4-4D74-BCCF-F1F19EE8198E Q36977382-0F11BB23-5DC8-4782-8286-29ECE8435B17 Q37123216-6E92D9BE-0CA9-4C11-BF78-758B04400188 Q37593694-36A04D01-58E6-4374-9BC9-848B9D214912 Q37807903-DC2F596E-71B9-4645-9227-F199FBEACA4B Q37832766-E1856EE4-3172-4410-96AB-FE9D19F68513 Q38084470-22A1DDCD-AEA9-4D02-A666-CA7DDBCF2685 Q38496987-D6B517B5-DC4B-4407-AC9C-FE1FACABE054 Q38946879-E7ED4C1E-B3A9-4C8A-BC7E-83BE809BA8E8

P2860

Administration of parenteral iron and mortality among hemodialysis patients.

http://www.wikidata.org/entity/Q47578282

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Administration of parenteral iron and mortality among hemodialysis patients.

@en

Administration of parenteral iron and mortality among hemodialysis patients.

@nl

type

label

Administration of parenteral iron and mortality among hemodialysis patients.

@en

Administration of parenteral iron and mortality among hemodialysis patients.

@nl

prefLabel

Administration of parenteral iron and mortality among hemodialysis patients.

@en

Administration of parenteral iron and mortality among hemodialysis patients.

@nl

P1433

Q47578282-347ED16E-B482-4B60-9C84-D5B31DC24E24

P1476

Q47578282-75E61310-B4E8-4752-8E9B-465D2B11CD86

P2093

Q47578282-1B857CC6-1C7D-4D3A-AB24-C84728A95CBB

Q47578282-344376A6-59CC-449E-BF24-3EFFE1B08BBC

Q47578282-4AB3E683-D116-40BC-8A3D-309AB351E537

Q47578282-744CD1C4-5269-40CA-B0C7-61A0649CA5EE

Q47578282-78A3A42A-56BA-46B6-96F3-69289FAD48F1

Q47578282-916E0292-CFD4-4F50-9F5D-F23175087764

Q47578282-E168F80D-AA69-4F24-986E-52E79F239B81

Q47578282-F9C409E1-37DB-400C-842A-F804A8933E8E

P304

Q47578282-7421B927-FDD8-48BD-B078-ED5814978ADD

P31

Q47578282-92596483-6D7D-45F4-95CC-500C2CF9114B

P356

Q47578282-BD649D6E-D911-423F-B4C5-999BDB3C9093

P433

Q47578282-66BAC7F9-6B8A-4B56-AEA7-2945C38738A2

P478

Q47578282-CF5BC0FD-D9B9-47DB-AD91-6B6BE2EE9790

P577

Q47578282-1D7E22F3-CAA1-41C3-A22E-5478EFEB3520

P5875

Q47578282-303C2876-3323-40E6-A3C9-18FBB486EB8C

P698

Q47578282-45C486C7-7CCE-457A-928F-9D557A939AF9

P921

Q47578282-595CD729-10E3-4B1E-B9EB-BDE5B5AA0509

P356

01.ASN.0000128009.69594.BE

P1433

Journal of the American Society of Nephrology

P1476

Administration of parenteral iron and mortality among hemodialysis patients.

@en

P2093

Borut Cizman

http://www.w3.org/2001/XMLSchema#string

Bruce Robinson

http://www.w3.org/2001/XMLSchema#string

Eunice Franklin-Becker

http://www.w3.org/2001/XMLSchema#string

Gerald Faich

http://www.w3.org/2001/XMLSchema#string

Harold I Feldman

http://www.w3.org/2001/XMLSchema#string

Jill Knauss

http://www.w3.org/2001/XMLSchema#string

Marshall Joffe

http://www.w3.org/2001/XMLSchema#string

Wensheng Guo

http://www.w3.org/2001/XMLSchema#string

P304

1623-1632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.ASN.0000128009.69594.BE

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8551905

http://www.w3.org/2001/XMLSchema#string

P698

15153574

http://www.w3.org/2001/XMLSchema#string

P921